NCT00005635View on ClinicalTrials.gov

Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

January 31, 2000

Primary Completion Date

November 30, 2001

Conditions

Breast Cancer

Interventions

BIOLOGICAL

trastuzumab

DRUG

paclitaxel

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Genentech, Inc.

INDUSTRY